Evidence map›Paper›PMID 32395544›Full record

ReviewAnnals of translational medicine2020

A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern.

Siya Zhao, Jin Cao, Qianling Shi, Zijun Wang, Janne Estill, Shuya Lu, Xufei Luo, Junxian Zhao, Hairong Zhang, Jianjian Wang and 13 more

Abstract readReview
In one paragraph

Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Maintaining neglected tropical disease programmes during pandemics.Bulletin of the World Health Organization · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Clinical practice guidelines for COVID-19.Integrative medicine research · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Siya ZhaoSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Jin CaoSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Qianling ShiEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Zijun WangEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Janne EstillInstitute of Global Health, University of Geneva, Geneva, Switzerland.
Shuya LuEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Xufei LuoSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Junxian ZhaoSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Hairong ZhangEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Jianjian WangSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Qi WangHealth Policy PhD Program, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
Yangqin XunSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Jingyi ZhangSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Meng LvSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Yunlan LiuSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Xiaomin NieThe Second Clinical Medical College of Lanzhou University, Lanzhou 730030, China.
Ling WangSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Xianzhuo ZhangEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Weiguo LiDepartment of Respiratory, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Enmei LiuDepartment of Respiratory, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Xiaohui WangSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Yaolong ChenEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
COVID-19 evidence and recommendations working group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This project aims to evaluate the methods and reporting quality of practice guidelines of five different viruses that have caused Public Health Emergencies of International Concern (PHEIC) over 20 past years: the severe acute respiratory syndrome coronavirus (SARS-CoV), Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We systematically searched databases, guideline websites and government health agency websites from their inception to February 02, 2020 to extract practice guidelines for SARS-CoV, Ebola virus, MERS-CoV, Zika virus, SARS-CoV-2 and the diseases they caused. The literature was screened independently by four researchers. Then, fifteen researchers evaluated the quality of included guidelines using the AGREE-II (Appraisal of Guidelines for Research and Evaluation II, for methodological quality) instrument and RIGHT (Reporting Items for practice Guidelines in Healthcare, for reporting quality) statement. Finally, a total of 81 guidelines were included, including 21 SARS-CoV guidelines, 11 Ebola virus (EBOV) guidelines, 9 MERS-CoV guidelines, 10 Zika Virus guidelines and 30 SARS-CoV-2 guidelines. The evaluation of the methodological quality indicated that the mean scores of each domain for guidelines of each virus were all below 60%, the scores for guidelines in the domains of "clarity of presentation" being the highest and in the "editorial independence" lowest. The mean reporting rate of each domain for guidelines of each virus was also less than 60%: the reporting rates for the domain "background" were highest, and for the domain "funding and interests" lowest. The methodological and reporting quality of the practice guidelines for SARS-CoV, Ebola virus, MERS-CoV, Zika virus and SARS-CoV-2 guidelines tend to be low. We recommend to follow evidence-based methodology and the RIGHT statement on reporting when developing guidelines.

Indexed as

CoronavirusEbola virus (EBOV)emergencypractice guidelineZika virus

Identifiers

PMID32395544
PMCPMC7210117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.